Study details
Enrolling now
CA 125 Algorithm for Early Ovarian Cancer Detection
M.D. Anderson Cancer Center
NCT IDNCT00539162ClinicalTrials.gov data as of Apr 2026
Target enrollment
8,000
Study length
about 27 years
Ages
50–74
Sex
Female only
Locations
11 sites in FL, IA, NJ +4
What this study is about
This trial is testing if a blood test called CA 125 can help detect ovarian cancer early in women at low risk. It involves questionnaires and will last about 10 years.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Questionnaire
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Oncology